1-230714126-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000679738.1(AGT):​n.-71G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.583 in 152,032 control chromosomes in the GnomAD database, including 28,516 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 28493 hom., cov: 31)
Exomes 𝑓: 0.48 ( 23 hom. )

Consequence

AGT
ENST00000679738.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.48

Publications

241 publications found
Variant links:
Genes affected
AGT (HGNC:333): (angiotensinogen) The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure, body fluid and electrolyte homeostasis, and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease. [provided by RefSeq, Nov 2019]
AGT Gene-Disease associations (from GenCC):
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 1-230714126-C-T is Benign according to our data. Variant chr1-230714126-C-T is described in ClinVar as Benign. ClinVar VariationId is 296090.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.835 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGTNM_001382817.3 linkc.-30-3273G>A intron_variant Intron 1 of 4 NP_001369746.2
AGTNM_001384479.1 linkc.-71G>A upstream_gene_variant ENST00000366667.6 NP_001371408.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGTENST00000366667.6 linkc.-71G>A upstream_gene_variant 1 NM_001384479.1 ENSP00000355627.5

Frequencies

GnomAD3 genomes
AF:
0.583
AC:
88384
AN:
151728
Hom.:
28429
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.842
Gnomad AMI
AF:
0.431
Gnomad AMR
AF:
0.640
Gnomad ASJ
AF:
0.448
Gnomad EAS
AF:
0.831
Gnomad SAS
AF:
0.624
Gnomad FIN
AF:
0.443
Gnomad MID
AF:
0.516
Gnomad NFE
AF:
0.421
Gnomad OTH
AF:
0.562
GnomAD4 exome
AF:
0.478
AC:
89
AN:
186
Hom.:
23
Cov.:
0
AF XY:
0.481
AC XY:
74
AN XY:
154
show subpopulations
African (AFR)
AF:
1.00
AC:
6
AN:
6
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
1
AN:
4
East Asian (EAS)
AF:
0.750
AC:
6
AN:
8
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
0.500
AC:
1
AN:
2
European-Non Finnish (NFE)
AF:
0.443
AC:
70
AN:
158
Other (OTH)
AF:
0.625
AC:
5
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.583
AC:
88505
AN:
151846
Hom.:
28493
Cov.:
31
AF XY:
0.587
AC XY:
43579
AN XY:
74194
show subpopulations
African (AFR)
AF:
0.843
AC:
34955
AN:
41472
American (AMR)
AF:
0.641
AC:
9783
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.448
AC:
1556
AN:
3470
East Asian (EAS)
AF:
0.831
AC:
4259
AN:
5128
South Asian (SAS)
AF:
0.622
AC:
2980
AN:
4788
European-Finnish (FIN)
AF:
0.443
AC:
4661
AN:
10514
Middle Eastern (MID)
AF:
0.493
AC:
145
AN:
294
European-Non Finnish (NFE)
AF:
0.421
AC:
28577
AN:
67884
Other (OTH)
AF:
0.566
AC:
1197
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
1631
3262
4893
6524
8155
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.488
Hom.:
54099
Bravo
AF:
0.610
Asia WGS
AF:
0.728
AC:
2530
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Renal tubular dysgenesis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypertension, essential, susceptibility to Benign:1
Dec 24, 2010
OMIM
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Renal tubular dysgenesis of genetic origin Benign:1
Apr 24, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.75
DANN
Benign
0.60
PhyloP100
-1.5
PromoterAI
-0.087
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5051; hg19: chr1-230849872; API